Saturday
SESSION 99: NEW DEVELOPMENTS IN THE TREATMENT OF DISEASES OF THE LOWER EXTREMITIES
SESSION 99 SCHEDULE
6:46 AM - 6:51 AM Why Patients Get Readmitted After Lower Extremity Procedures And How To Solve The Readmission Problem
  Presenter(s):Todd R. Vogel, MD, MPH  
  View Slides in PDF      
6:52 AM - 6:57 AM 12-Month Results Of Different Strategies For Using The 4-French Pulsar-18 Self-Expandable Nitinol Stent For Treatment Of Femoropopliteal Occlusive Lesions: Do Supplemental DCBs Or Atherectomy Improve Outcomes
  Presenter(s):Michael K.W. Lichtenberg, MD  
  View Slides in PDF      
6:58 AM - 7:03 AM Medicare Data Comparing Endovascular And Open Revascularizations For Peripheral Arterial Disease: What New And Interesting Information Does It Provide
  Presenter(s):K. Craig Kent, MD  
  View Slides in PDF      
7:04 AM - 7:09 AM What Are The Disadvantages And Limitations Of The Supera Stent
  Presenter(s):Gabriel Szendro, MD  
  View Slides in PDF      
7:10 AM - 7:15 AM The Wingman CTO Catheter: A New Innovative CTO Recanalization Device (From ReFlow Medical) For Crossing Long Difficult Occlusions: How It Works And Results
  Presenter(s):Michael K.W. Lichtenberg, MD  
7:16 AM - 7:21 AM Strategies For Treating Occluded Popliteal Arteries With No Trifurcation Outflow Endovascularly
  Presenter(s):George H. Meier III, MD  
  View Slides in PDF      
7:22 AM - 7:27 AM Value Of An Implantable O2 Sensor In Treating Lower Extremity Disease: The Lumee Device And The Global Experience With It
  Presenter(s):Miguel F. Montero-Baker, MD  
  View Slides in PDF      
7:28 AM - 7:34 AM Panel Discussion
Moderator(s): Gregg S. Landis, MD / K. Craig Kent, MD  
7:34 AM - 7:39 AM Experience With A New BioMimics 3-Dimensional Helical Stent In Fempop Arteries: Why Is It Different And What Are Its Theoretical And Clilnical Advantages
  Presenter(s):Michael K.W. Lichtenberg, MD / Thomas Zeller, MD  
  View Slides in PDF      
DRUG ELUTING STENTS (DESS)
7:40 AM - 7:45 AM 5-Year Experience With Coronary DESs In The Tibial And Peroneal Arteries
  Presenter(s):Michael J. Wilderman, MD  
  View Slides in PDF      
DRUG COATED BALLOONS (DCBS)
7:46 AM - 7:51 AM Comparative Performance Of DCBs In Women; And In Diabetics In The In.Pact SFA And Lutonix Trials
  Presenter(s):Peter A. Schneider, MD  
  View Slides in PDF      
7:52 AM - 7:57 AM Value Of Pre-Clinical Studies Of DCBs: All DCBs Are Not Equal: How Can Performance Be Predicted: Will DCBs Ever Work Effectively In BTK Arteries
  Presenter(s):Renu Virmani, MD  
  View Slides in PDF      
7:58 AM - 8:03 AM Differences And Similarities In All The DCB Registries And RCTs: All DCBs And All Studies Are Not Equal
  Presenter(s):Marianne Brodmann, MD  
  View Slides in PDF      
8:04 AM - 8:09 AM What Is The Economic Impact Of DCBs On A Global Level: They Are Cost Effective
  Presenter(s):Ulrich Beschorner, MD / Thomas Zeller, MD  
  View Slides in PDF      
8:10 AM - 8:16 AM Panel Discussion
END OF SESSION 99
previous next